Metabolic syndrome, mild cognitive impairment and Alzheimer's disease-The emerging role of systemic low-grade inflammation and adiposity

Brain Research Bulletin

Volumn 89, Issue 3-4, 2012, Pages 144-149

  Misiak, Blazej ^a   Leszek, Jerzy ^a   Kiejna, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Adiposity; Alzheimer's disease; Inflammation; Metabolic syndrome; Mild cognitive impairment

Indexed keywords

ADIPONECTIN; AMYLOID PRECURSOR PROTEIN; CYTOKINE;

ADIPOSE TISSUE; ALZHEIMER DISEASE; HUMAN; HYPERLEPTINEMIA; INFLAMMATION; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADIPOSITY; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; METABOLIC DISEASES; MILD COGNITIVE IMPAIRMENT;

EID: 84866350782     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.08.003     Document Type: Review

References (89)

1. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Current Pharmaceutical Design 2005, 11:973-984.
2. Barrett-Connor E., Edelstein S., Corey-Bloom J., Wiederholt W. Weight loss precedes dementia in community-dwelling older adults. Journal of Nutrition, Health and Aging 1998, 2:113-114.
3. Bellini M.J., Herenu C.B., Goya R.G., Garcia-Segura L.M. Insulin-like growth factor-I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide. Journal of Neuroinflammation 2011, 8:21.
4. Bełtowski J. Leptin and the regulation of endothelial function in physiological and pathological conditions. Clinical and Experimental Pharmacology & Physiology 2012, 39:168-178.
5. Bigalke B., Schreitmuller B., Sopova K., Paul A., Stransky E., Gawaz M., Stellos K., Laske C. Adipocytokines and CD34 progenitor cells in Alzheimer's disease. PLoS ONE 2011, 6:e20286.
6. Blach-Olszewska Z., Leszek J. Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders. Neuropsychiatric Disease and Treatment 2007, 3:365-372.
7. Caldefie-Chezet F., Poulin A., Vasson M.P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radical Research 2003, 37:809-814.
8. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-β levels. Nature Medicine 2002, 8:1390-1397.
9. Chen K., Li F., Li J., Cai H., Strom S., Bisello A., Kelley D.E., Friedman-Einat M., Skibinski G.A., McCrory M.A., Szalai A.J., Zhao A.Z. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nature Medicine 2006, 12:425-432.
10. Cosentino S.A., Stern Y., Sokolov E., Scarmeas N., Manly J.J., Tang M.X., Schupf N., Mayeux R.P. Plasma β-amyloid and cognitive decline. Archives of Neurology 2010, 67:1485-1490.
11. de la Torre J.C. The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neuro-degenerative Diseases 2010, 7:116-121.
12. De Rosa S., Cirillo P., Pacileo M., Di Palma V., Paglia A., Chiariello M. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. Journal of Vascular Research 2009, 46:609-617.
13. Dik M.G., Jonker C., Comijs H.C., Deeg D.J., Kok A., Yaffe K., Penninx B.W. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007, 30:2655-2660.
14. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., Eckman C.B., Tanzi R.E., Selkoe D.J., Guenette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:4162-4167.
15. Fewlass D.C., Noboa K., Pi-Sunyer F.X., Johnston J.M., Yan S.D., Tezapsidis N. Obesity-related leptin regulates Alzheimer's Aβ. FASEB Journal 2004, 18:1870-1878.
16. Fishel M.A., Watson G.S., Montine T.J., Wang Q., Green P.S., Kulstad J.J., Cook D.G., Peskind E.R., Baker L.D., Goldgaber D., Nie W., Asthana S., Plymate S.R., Schwartz M.W., Craft S. Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults. Archives of Neurology 2005, 62:1539-1544.
17. Fodero-Tavoletti M.T., Villemagne V.L., Rowe C.C., Masters C.L., Barnham K.J., Cappai R. Amyloid-β: the seeds of darkness. International Journal of Biochemistry and Cell Biology 2011, 43:1247-1251.
18. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Research. Molecular Brain Research 1992, 16:128-134.
19. Frisardi V., Solfrizzi V., Seripa D., Capurso C., Santamato A., Sancarlo D., Vendemiale G., Pilotto A., Panza F. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Research Reviews 2010, 9:399-417.
20. Frolich L., Blum-Degen D., Bernstein H.G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Turk A., Hoyer S., Zochling R., Boissl K.W., Jellinger K., Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. Journal of Neural Transmission 1998, 105:423-438.
21. Funahashi H., Yada T., Suzuki R., Shioda S. Distribution, function, and properties of leptin receptors in the brain. International Review of Cytology 2003, 224:1-27.
22. Gallagher E.J., Leroith D., Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mount Sinai Journal of Medicine 2010, 77:511-523.
23. Gu Y., Luchsinger J.A., Stern Y., Scarmeas N. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. Journal of Alzheimer's Disease 2010, 22:483-492.
24. Guo Z., Jiang H., Xu X., Duan W., Mattson M.P. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. Journal of Biological Chemistry 2008, 283:1754-1763.
25. Gurol M.E., Irizarry M.C., Smith E.E., Raju S., Diaz-Arrastia R., Bottiglieri T., Rosand J., Growdon J.H., Greenberg S.M. Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006, 66:23-29.
26. Gustafson B. Adipose tissue, inflammation and atherosclerosis. Journal of Atherosclerosis and Thrombosis 2010, 17:332-341.
27. Hao Z., Wu B., Wang D., Liu M. Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies. Acta Neuropsychiatrica 2011, 23:69-74.
28. Harwood H.J. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2012, 63:57-75.
29. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. Journal of Neural Transmission 1998, 105:415-422.
30. Hoyer S. Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism. Journal of Neural Transmission Supplementum 1998, 54:187-194.
31. Inoue W., Poole S., Bristow A.F., Luheshi G.N. Leptin induces cyclooxygenase-2 via an interaction with interleukin-1β in the rat brain. European Journal of Neuroscience 2006, 24:2233-2245.
32. Irizarry M.C. Biomarkers of Alzheimer disease in plasma. NeuroRx: The Journal of the American Society for Experimental NeuroTherapeutics 2004, 1:226-234.
33. Isobe T., Saitoh S., Takagi S., Takeuchi H., Chiba Y., Katoh N., Shimamoto K. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. European Journal of Endocrinology/European Federation of Endocrine Societies 2005, 153:91-98.
34. Jatczak B., Leszek J., Siemieniec I., Sochocka M., Wisniewska A., Tarkowski R., Bebenek M., Blach-Olszewska Z. Age- and disease-related innate immunity of human leukocytes ex vivo. Experimental Gerontology 2012, 47:8-13.
35. Katsumata Y., Todoriki H., Higashiuesato Y., Yasura S., Willcox D.C., Ohya Y., Willcox B.J., Dodge H.H. Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA project. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2012, 67:126-134.
36. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112:1756-1762.
37. Kitazawa M., Cheng D., Tsukamoto M.R., Koike M.A., Wes P.D., Vasilevko V., Cribbs D.H., LaFerla F.M. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model. Journal of Immunology 2011, 187:6539-6549.
38. Lafrance V., Inoue W., Kan B., Luheshi G.N. Leptin modulates cell morphology and cytokine release in microglia. Brain, Behavior, and Immunity 2010, 24:358-365.
39. Lam Q.L., Liu S., Cao X., Lu L. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. European Journal of Immunology 2006, 36:3118-3130.
40. Lam Q.L., Lu L. Role of leptin in immunity. Cellular & Molecular Immunology 2007, 4:1-13.
41. Laughlin G.A., Barrett-Connor E., May S., Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. American Journal of Epidemiology 2007, 165:164-174.
42. Lee E.B. Obesity, leptin, and Alzheimer's disease. Annals of the New York Academy of Sciences 2011, 1243:15-29.
43. Lee Y.H., Tharp W.G., Maple R.L., Nair S., Permana P.A., Pratley R.E. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) 2008, 16:1493-1500.
44. Li Y., Liu L., Barger S.W., Griffin W.S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. Journal of Neuroscience 2003, 23:1605-1611.
45. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:7047-7052.
46. Madsen E.L., Rissanen A., Bruun J.M., Skogstrand K., Tonstad S., Hougaard D.M., Richelsen B. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology/European Federation of Endocrine Societies 2008, 158:179-187.
47. Mangge H., Almer G., Haj-Yahya S., Grandits N., Gasser R., Pilz S., Moller R., Horejsi R. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis 2009, 203:277-283.
48. Mangge H., Almer G., Haj-Yahya S., Pilz S., Gasser R., Moller R., Horejsi R. Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring) 2008, 16:2578-2584.
49. Mangge H., Almer G., Truschnig-Wilders M., Schmidt A., Gasser R., Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Current Medicinal Chemistry 2010, 17:4511-4520.
50. Martin S.S., Qasim A., Reilly M.P. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 2008, 52:1201-1210.
51. Mattioli B., Straface E., Quaranta M.G., Giordani L., Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. Journal of Immunology 2005, 174:6820-6828.
52. Moloney A.M., Griffin R.J., Timmons S., O'Connor R., Ravid R., O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiology of Aging 2010, 31:224-243.
53. Monteiro R., Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators of Inflammation 2010, 2010.
54. Motta M., Bennati E., Cardillo E., Passamonte M., Ferlito L., Malaguarnera M. The metabolic syndrome (MS) in the elderly: considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modifications. Archives of Gerontology and Geriatrics 2009, 48:380-384.
55. Mozaffarian D., Kamineni A., Prineas R.J., Siscovick D.S. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Archives of Internal Medicine 2008, 168:969-978.
56. Nourhashemi F., Deschamps V., Larrieu S., Letenneur L., Dartigues J.F., Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID Study. Neurology 2003, 60:117-119.
57. O'Malley D., MacDonald N., Mizielinska S., Connolly C.N., Irving A.J., Harvey J. Leptin promotes rapid dynamic changes in hippocampal dendritic morphology. Molecular and Cellular Neurosciences 2007, 35:559-572.
58. Panza F., Frisardi V., Capurso C., Imbimbo B.P., Vendemiale G., Santamato A., D'Onofrio G., Seripa D., Sancarlo D., Pilotto A., Solfrizzi V. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. Journal of Alzheimer's Disease 2010, 21:691-724.
59. Park S.E., Dantzer R., Kelley K.W., McCusker R.H. Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. Journal of Neuroinflammation 2011, 8:12.
60. Paz-Filho G., Wong M.L., Licinio J. The procognitive effects of leptin in the brain and their clinical implications. International Journal of Clinical Practice 2010, 64:1808-1812.
61. Pinteaux E., Inoue W., Schmidt L., Molina-Holgado F., Rothwell N.J., Luheshi G.N. Leptin induces interleukin-1β release from rat microglial cells through a caspase 1 independent mechanism. Journal of Neurochemistry 2007, 102:826-833.
62. Qiu W.Q., Folstein M.F. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis. Neurobiology of Aging 2006, 27:190-198.
63. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. Journal of Biological Chemistry 1998, 273:32730-32738.
64. Quintanilla R.A., Orellana D.I., Gonzalez-Billault C., Maccioni R.B. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Experimental Cell Research 2004, 295:245-257.
65. Reger M.A., Craft S. Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs Today (Barc) 2006, 42:729-739.
66. Reger M.A., Watson G.S., Frey W.H., Baker L.D., Cholerton B., Keeling M.L., Belongia D.A., Fishel M.A., Plymate S.R., Schellenberg G.D., Cherrier M.M., Craft S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiology of Aging 2006, 27:451-458.
67. Roberts R.O., Geda Y.E., Knopman D.S., Cha R.H., Boeve B.F., Ivnik R.J., Pankratz V.S., Tangalos E.G., Petersen R.C. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Disease and Associated Disorders 2010, 24:11-18.
68. Russo V.C., Metaxas S., Kobayashi K., Harris M., Werther G.A. Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004, 145:4103-4112.
69. Sachot C., Poole S., Luheshi G.N. Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. The Journal of Physiology 2004, 561:263-272.
70. Sell H., Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Current Opinion in Clinical Nutrition and Metabolic Care 2010, 13:366-370.
71. Sheng J.G., Jones R.A., Zhou X.Q., McGinness J.M., Van Eldik L.J., Mrak R.E., Griffin W.S. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochemistry International 2001, 39:341-348.
72. Shimabukuro M., Wang M.Y., Zhou Y.T., Newgard C.B., Unger R.H. Protection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:9558-9561.
73. Simi A., Lerouet D., Pinteaux E., Brough D. Mechanisms of regulation for interleukin-1β in neurodegenerative disease. Neuropharmacology 2007, 52:1563-1569.
74. Solfrizzi V., Scafato E., Capurso C., D'Introno A., Colacicco A.M., Frisardi V., Vendemiale G., Baldereschi M., Crepaldi G., Di Carlo A., Galluzzo L., Gandin C., Inzitari D., Maggi S., Capurso A., Panza F. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiology of Aging 2011, 32:1932-1941.
75. Stewart R., Masaki K., Xue Q.L., Peila R., Petrovitch H., White L.R., Launer L.J. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Archives of Neurology 2005, 62:55-60.
76. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry 2010, 68:930-941.
77. Togashi H., Mori K., Itoh Y., Matsumoto M., Ueno K., Ohashi S., Otani H., Yoshioka M. Involvement of interleukin-1β/nitric oxide pathway in the postischemic impairment of long-term potentiation of the rat hippocampus. Neuroscience Letters 2001, 313:133-136.
78. Udagawa J., Hashimoto R., Hioki K., Otani H. The role of leptin in the development of the cortical neuron in mouse embryos. Brain Research 2006, 1120:74-82.
79. Une K., Takei Y.A., Tomita N., Asamura T., Ohrui T., Furukawa K., Arai H. Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. European Journal of Neurology 2011, 18:1006-1009.
80. van Himbergen T.M., Beiser A.S., Ai M., Seshadri S., Otokozawa S., Au R., Thongtang N., Wolf P.A., Schaefer E.J. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study. Archives of Neurology 2012, 69:594-600.
81. Villemagne V.L., Perez K.A., Pike K.E., Kok W.M., Rowe C.C., White A.R., Bourgeat P., Salvado O., Bedo J., Hutton C.A., Faux N.G., Masters C.L., Barnham K.J. Blood-borne amyloid-β dimer correlates with clinical markers of Alzheimer's disease. Journal of Neuroscience 2010, 30:6315-6322.
82. Vinluan C.M., Zreikat H.H., Levy J.R., Cheang K.I. Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly. Metabolism 2012, 61:302-309.
83. Wannamethee S.G., Whincup P.H., Lennon L., Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Archives of Internal Medicine 2007, 167:1510-1517.
84. Watson G.S., Bernhardt T., Reger M.A., Cholerton B.A., Baker L.D., Peskind E.R., Asthana S., Plymate S.R., Frolich L., Craft S. Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiology of Aging 2006, 27:38-41.
85. Xie L., Helmerhorst E., Taddei K., Plewright B., Van Bronswijk W., Martins R. Alzheimer's β-amyloid peptides compete for insulin binding to the insulin receptor. The Journal of Neuroscience 2002, 22:RC221.
86. Yaffe K., Haan M., Blackwell T., Cherkasova E., Whitmer R.A., West N. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. Journal of the American Geriatrics Society 2007, 55:758-762.
87. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B. The metabolic syndrome, inflammation, and risk of cognitive decline. The Journal of the American Medical Association 2004, 292:2237-2242.
88. Yang Y., Quitschke W.W., Brewer G.J. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester IL-1 and retinoic acid, but not by reactive oxygen species. Brain Research. Molecular Brain Research 1998, 60:40-49.
89. Zhao Y., Sun R., You L., Gao C., Tian Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochemical and Biophysical Research Communications 2003, 300:247-252.